vs

Side-by-side financial comparison of LATTICE SEMICONDUCTOR CORP (LSCC) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $145.8M, roughly 1.5× LATTICE SEMICONDUCTOR CORP). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs -5.2%, a 24.6% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 9.3%). LATTICE SEMICONDUCTOR CORP produced more free cash flow last quarter ($44.0M vs $34.8M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 8.4%).

Lattice Semiconductor Corporation is an American semiconductor company specializing in the design and manufacturing of low power field-programmable gate arrays (FPGAs). Headquartered in the Silicon Forest area of Hillsboro, Oregon, the company also has operations in San Jose, Calif., Shanghai, Manila, Penang, and Singapore. Lattice Semiconductor has more than 1000 employees and an annual revenue of more than $660 million as of 2022. The company was founded in 1983 and went public in 1989. It ...

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

LSCC vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.5× larger
ORGO
$225.6M
$145.8M
LSCC
Growing faster (revenue YoY)
ORGO
ORGO
+68.8% gap
ORGO
78.1%
9.3%
LSCC
Higher net margin
ORGO
ORGO
24.6% more per $
ORGO
19.4%
-5.2%
LSCC
More free cash flow
LSCC
LSCC
$9.2M more FCF
LSCC
$44.0M
$34.8M
ORGO
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
8.4%
LSCC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
LSCC
LSCC
ORGO
ORGO
Revenue
$145.8M
$225.6M
Net Profit
$-7.6M
$43.7M
Gross Margin
68.5%
Operating Margin
30.7%
28.1%
Net Margin
-5.2%
19.4%
Revenue YoY
9.3%
78.1%
Net Profit YoY
14.6%
469.5%
EPS (diluted)
$-0.06
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LSCC
LSCC
ORGO
ORGO
Q1 26
$145.8M
Q4 25
$225.6M
Q3 25
$133.3M
$150.9M
Q2 25
$124.0M
$101.0M
Q1 25
$120.2M
$86.7M
Q4 24
$117.4M
$126.7M
Q3 24
$127.1M
$115.2M
Q2 24
$124.1M
$130.2M
Net Profit
LSCC
LSCC
ORGO
ORGO
Q1 26
$-7.6M
Q4 25
$43.7M
Q3 25
$2.8M
$21.6M
Q2 25
$2.9M
$-9.4M
Q1 25
$5.0M
$-18.8M
Q4 24
$16.5M
$7.7M
Q3 24
$7.2M
$12.3M
Q2 24
$22.6M
$-17.0M
Gross Margin
LSCC
LSCC
ORGO
ORGO
Q1 26
68.5%
Q4 25
Q3 25
67.9%
Q2 25
68.4%
Q1 25
68.0%
72.6%
Q4 24
61.1%
75.5%
Q3 24
69.0%
76.7%
Q2 24
68.3%
77.6%
Operating Margin
LSCC
LSCC
ORGO
ORGO
Q1 26
0.7%
Q4 25
28.1%
Q3 25
-1.2%
13.7%
Q2 25
3.8%
-12.5%
Q1 25
5.8%
-30.9%
Q4 24
-10.4%
8.1%
Q3 24
5.9%
5.4%
Q2 24
18.2%
-10.7%
Net Margin
LSCC
LSCC
ORGO
ORGO
Q1 26
-5.2%
Q4 25
19.4%
Q3 25
2.1%
14.3%
Q2 25
2.3%
-9.3%
Q1 25
4.2%
-21.7%
Q4 24
14.1%
6.1%
Q3 24
5.7%
10.7%
Q2 24
18.2%
-13.1%
EPS (diluted)
LSCC
LSCC
ORGO
ORGO
Q1 26
$-0.06
Q4 25
$0.31
Q3 25
$0.02
$0.11
Q2 25
$0.02
$-0.10
Q1 25
$0.04
$-0.17
Q4 24
$0.12
$0.05
Q3 24
$0.05
$0.09
Q2 24
$0.16
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LSCC
LSCC
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$133.9M
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$714.1M
$300.1M
Total Assets
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LSCC
LSCC
ORGO
ORGO
Q1 26
$133.9M
Q4 25
$93.7M
Q3 25
$117.9M
$63.7M
Q2 25
$107.2M
$73.1M
Q1 25
$127.6M
$110.0M
Q4 24
$136.3M
$135.6M
Q3 24
$124.3M
$94.3M
Q2 24
$109.2M
$89.9M
Total Debt
LSCC
LSCC
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
LSCC
LSCC
ORGO
ORGO
Q1 26
$714.1M
Q4 25
$300.1M
Q3 25
$706.4M
$255.1M
Q2 25
$687.0M
$233.2M
Q1 25
$707.9M
$242.9M
Q4 24
$710.9M
$262.9M
Q3 24
$703.5M
$278.5M
Q2 24
$698.8M
$263.5M
Total Assets
LSCC
LSCC
ORGO
ORGO
Q1 26
$883.1M
Q4 25
$598.7M
Q3 25
$844.4M
$509.8M
Q2 25
$808.6M
$461.1M
Q1 25
$823.6M
$467.4M
Q4 24
$843.9M
$497.9M
Q3 24
$853.7M
$446.3M
Q2 24
$827.5M
$443.2M
Debt / Equity
LSCC
LSCC
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LSCC
LSCC
ORGO
ORGO
Operating Cash FlowLast quarter
$57.6M
$39.4M
Free Cash FlowOCF − Capex
$44.0M
$34.8M
FCF MarginFCF / Revenue
30.2%
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$153.3M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LSCC
LSCC
ORGO
ORGO
Q1 26
$57.6M
Q4 25
$39.4M
Q3 25
$47.1M
$3.1M
Q2 25
$38.5M
$-32.9M
Q1 25
$31.9M
$-19.9M
Q4 24
$45.4M
$10.9M
Q3 24
$44.0M
$8.7M
Q2 24
$21.9M
$4.7M
Free Cash Flow
LSCC
LSCC
ORGO
ORGO
Q1 26
$44.0M
Q4 25
$34.8M
Q3 25
$34.0M
$844.0K
Q2 25
$31.3M
$-36.5M
Q1 25
$23.3M
$-23.6M
Q4 24
$39.7M
$7.6M
Q3 24
$39.4M
$6.1M
Q2 24
$14.8M
$2.9M
FCF Margin
LSCC
LSCC
ORGO
ORGO
Q1 26
30.2%
Q4 25
15.4%
Q3 25
25.5%
0.6%
Q2 25
25.2%
-36.1%
Q1 25
19.4%
-27.2%
Q4 24
33.8%
6.0%
Q3 24
31.0%
5.3%
Q2 24
11.9%
2.2%
Capex Intensity
LSCC
LSCC
ORGO
ORGO
Q1 26
9.3%
Q4 25
2.1%
Q3 25
9.8%
1.5%
Q2 25
5.8%
3.6%
Q1 25
7.2%
4.2%
Q4 24
4.9%
2.7%
Q3 24
3.7%
2.2%
Q2 24
5.8%
1.4%
Cash Conversion
LSCC
LSCC
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
16.86×
0.14×
Q2 25
13.23×
Q1 25
6.35×
Q4 24
2.75×
1.43×
Q3 24
6.12×
0.71×
Q2 24
0.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons